Tag Archives: AMGN

No Comments

CBOE Mid-Day Update 8.4.14

Volatility as an asset class Amgen (AMGN) is recently up $1.41 to $126.95 after the company reported its Phase 3 clinical trial ASPIRE met its primary endpoint of progression-free survival. August weekly call option implied volatility is at 22, September is at 23, October is at 21; compared to its 26-week average of 23. Michael […]






No Comments

Cusick’s Corner: Stocks Wobble on Worry

Stock market averages gave up modest midday gains and finished with losses Monday. Trading was a bit cautious early after European markets moved mostly lower to start the week and the only domestic economic stat of the day showed Durable Goods down 7.3 percent for July, which was worse than the -5 percent that was […]






No Comments

Blogging Options: CBOE Morning Update 7.31.13

Volatility as an asset class Amgen (AMGN) is recently down $2.55 to $108.65 on lower than expected Q2 earnings on increased research and development costs.  Overall option implied volatility of 26 is above its 26-week average of 23. Buffalo Wild Wings (BWLD) is up $1.52 to $99.21 in the premarket on inline Q2 earnings and concerns […]






No Comments

Weekend Review – 6/14/2013

Options Action – The traders addressed the impact of higher interest rates on the stock market.  One thought is that stocks that pay big dividends that have benefitted from lower rates, may come under pressure.  It was mentioned that several of these types of stocks have been under pressure already, but many also still appear […]